Overview

Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Thirty-six subjects with hyperlipidemia and metabolic syndrome and/or diabetes were randomized in a double-blind manner to either pravastatin 80 mg or atorvastatin 10 mg daily. Oxidative stress (dROMs assay that measures lipid hydroperoxides, plasma thiobarbituric acid reactive substances [TBARS], and aminothiol levels) and brachial artery flow-mediated dilation (FMD) were measured at baseline and after 12 weeks of statin therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Treatments:
Atorvastatin
Atorvastatin Calcium
Pravastatin